Displaying drugs 10201 - 10225 of 10948 in total
OBI-3424
OBI-3424 is under investigation in clinical trial NCT04315324 (Study to Test Akr1c3-activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/refractory T-cell Acute Lymphoblastic Leukemia (T-ALL)).
Investigational
Matched Description: … OBI-3424 is under investigation in clinical trial NCT04315324 (Study to Test Akr1c3-activated Prodrug ... OBI-3424 (OBI-3424) in Patients With Relapsed/refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) …
FavId
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational
DSP107
DSP107 is a bi-functional, trimeric, fusion protein composed of sequences from the extracellular domain of SIRPĪ± and 4-1BBL.
Investigational
Matched Description: … of SIRPĪ± and 4-1BBL. ... DSP107 is a bi-functional, trimeric, fusion protein composed of sequences from the extracellular domain …
Tiamulin
Tiamulin is a pleuromutilin antibiotic drug that is used in veterinary medicine particularly for pigs and poultry.
Vet approved
Matched Description: … Tiamulin is a pleuromutilin antibiotic drug that is used in veterinary medicine particularly for pigs …
Pyrifazimine
Pyrifazimine is under investigation in clinical trial NCT04670120 (Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)).
Investigational
Matched Description: … Pyrifazimine is under investigation in clinical trial NCT04670120 (Early Bactericidal Activity Safety …
Pranlukast
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
Investigational
Matched Description: … It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to …
Matched Salts cas: … 150821-03-7 …
Matched Salts cas: … 150821-03-7 …
N-Ethylretinamide
N-Ethylretinamide is the ethylamide of all-trans B-retinoic acid.
Experimental
Matched Description: … N-Ethylretinamide is the ethylamide of all-trans B-retinoic acid. …
PF-4191834
PF-4191834 has been investigated for the basic science of Asthma.
Investigational
Matched Description: … PF-4191834 has been investigated for the basic science of Asthma. …
Brivanib alaninate
Brivanib alaninate has been investigated for the treatment of Colorectal Cancer.
Investigational
Matched Description: … Brivanib alaninate has been investigated for the treatment of Colorectal Cancer. …
Pelubiprofen
Pelubiprofen has been investigated for the treatment of Chronic Back Pain.
Investigational
Matched Description: … Pelubiprofen has been investigated for the treatment of Chronic Back Pain. …
N-acetylmannosamine
N-acetylmannosamine is under investigation for the other of GNE Myopathy.
Investigational
Matched Description: … N-acetylmannosamine is under investigation for the other of GNE Myopathy. …
Ezutromid
Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.
Investigational
Matched Description: … Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne. …
Olitigaltin
Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.
Investigational
Matched Description: … Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis. …
Sepranolone
Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder.
Investigational
Matched Iupac: … 1-[(1S,3aS,3bR,5aS,7S,9aS,9bS,11aS)-7-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren …
Matched Description: … Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder. …
Matched Description: … Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder. …
Apc001
Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta.
Investigational
Matched Description: … Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta. …
TBX-1400
TBX-1400 consists of human donor hematopoietic stem and progenitor cells.
Investigational
Matched Description: … TBX-1400 consists of human donor hematopoietic stem and progenitor cells. …
BCX10013
BCX10013 is a small molecule inhibitor of human complement factor D.
Investigational
Matched Description: … BCX10013 is a small molecule inhibitor of human complement factor D. …
Pipequaline
Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed. It presents a unique chemical structure that does not follow the structural properties of other drugs of its class. Pipequaline has a similar pharmacological profile to the reported for the benzodiazepines. However, it...
Experimental
Matched Description: … of its class. ... It presents a unique chemical structure that does not follow the structural properties of other drugs ... However, it presents a significant set of anxiolytic properties with a very little sedative, amnestic …
Tucotuzumab celmoleukin
Tucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment).
Investigational
Matched Description: … Tucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined ... With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not …
OC-459
OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.
Investigational
Matched Description: … OC000459 has been investigated for the treatment of Bronchial Asthma. ... OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. …
Zaltoprofen
A non-steroidal anti-inflammatory drug approved for use in Japan in 1993.
Experimental
Matched Description: … A non-steroidal anti-inflammatory drug approved for use in Japan in 1993. …
R-95845
R-95845 is an inhibitor of HIV-1 reverse transcriptase.
Experimental
Matched Description: … R-95845 is an inhibitor of HIV-1 reverse transcriptase. …
Pefcalcitol
Pefcalcitol has been investigated for the basic science of Psoriasis.
Investigational
Matched Iupac: … 2-[(1S)-1-[(3aS,7E,7aS)-7-{2-[(1Z,3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-3a-methyl …
Matched Description: … Pefcalcitol has been investigated for the basic science of Psoriasis. …
Matched Description: … Pefcalcitol has been investigated for the basic science of Psoriasis. …
Visilizumab
Visilizumab has been investigated for the treatment of Ulcerative Colitis.
Investigational
Matched Description: … Visilizumab has been investigated for the treatment of Ulcerative Colitis. …
Nitroaspirin
Nitroaspirin has been investigated for the treatment of Intermittent Claudication.
Investigational
Matched Description: … Nitroaspirin has been investigated for the treatment of Intermittent Claudication. …
Displaying drugs 10201 - 10225 of 10948 in total